Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples